Rubric Capital Management (New York)’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,478	Closed	-$5.17M	–	88
2022 Q2	$5.17M	Buy	24,478 +7,695	+46%	+$1.63M	0.27%	59
2022 Q1	$5.62M	Buy	+16,783	New	+$5.62M	0.2%	55